Titlebook: Biopharmaceutical Manufacturing; Progress, Trends and Ralf P?rtner Book 2023 The Editor(s) (if applicable) and The Author(s), under exclusi

McKinley

書目名稱Biopharmaceutical Manufacturing影響因子(影響力)




書目名稱Biopharmaceutical Manufacturing影響因子(影響力)學(xué)科排名




書目名稱Biopharmaceutical Manufacturing網(wǎng)絡(luò)公開度




書目名稱Biopharmaceutical Manufacturing網(wǎng)絡(luò)公開度學(xué)科排名




書目名稱Biopharmaceutical Manufacturing被引頻次




書目名稱Biopharmaceutical Manufacturing被引頻次學(xué)科排名




書目名稱Biopharmaceutical Manufacturing年度引用




書目名稱Biopharmaceutical Manufacturing年度引用學(xué)科排名




書目名稱Biopharmaceutical Manufacturing讀者反饋




書目名稱Biopharmaceutical Manufacturing讀者反饋學(xué)科排名

lobster

Emg827

Advances in Characterization of Industrial Bioreactors for Cell Culture Process of uses. This book chapter provides an overview of the main characterization methods for aerated stirred tank reactors in the context of cell culture processes. The methods described include mechanical power input, volumetric mass transfer, flow field, and mixing characterization. Examples are give

可卡

Congeal

Continuous Bioprocessing for Downstreamreasing equipment footprint and increase equipment utilization. For the interested reader this chapter provides an overview over the main developments in continuous downstream processing of biopharmaceuticals and introduces the main unit operations such as continuous chromatography, continuous filtr

MEAN

Towards Digital Twin for Biopharmaceutical Processes: Concept and Progressopharmaceutical manufacturing field. The realization of DT could help reduce cost, improve productivity, maintain high and constant product quality, and meet Quality-by-Design (QbD) guidelines. Nonetheless, the development of DT is still at its infancy stage and an integrated DT in biopharma is rare

OATH

NAV

Production of Complex Proteins in Plants: From Farming to Manufacturingl host cells cannot produce complex biopharmaceuticals that require defined oligomerization or specific glycosylation profiles, and mammalian cells are unsuitable for the production of toxic proteins. These issues are readily overcome by plant cell cultures, which have the machinery required for com

慢跑鞋

形狀

Biopharma 4.0 for Biologics Manufacturing Under Pandemic Constraintslow doses and less side effects. Biopharma 4.0 relates to the fourth industrial revolution based on digitalization. Digitalization has reached biopharmaceutical industry along the whole development and value chain. Biologics manufacturing of such complex three-dimensional molecules in correct foldin